IFNG and melanoma: Analysis performed in 14 patients showed (Fig 3A), that intracellular IFN-γ response to Iomomycin/PMA stimulation declined over time after melanoma removal, as compared to the response observed in the same patients before melanoma removal; IFN-γ response to Zoledronate stimulation also decreased after melanoma removal, but differences did not attain statistical significance.